Literature DB >> 9880278

Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.

J Hyett1, M Perdu, G Sharland, R Snijders, K H Nicolaides.   

Abstract

OBJECTIVES: To examine the utility of measuring fetal nuchal translucency thickness in screening for major defects of the heart and great arteries at 10-14 weeks of gestation.
DESIGN: Population based cohort study.
SUBJECTS: 29 154 singleton pregnancies with chromosomally normal fetuses at 10-14 weeks of gestation.
SETTING: Fetal medicine centre in London. MAIN OUTCOME MEASURE: Prevalence of major defects of the heart and great arteries.
RESULTS: Of 50 cases with major defects of the heart and great arteries (prevalence 1.7 per 1000 pregnancies) 28 (56%, 95% confidence interval 42% to 70%) were in the subgroup of 1822 pregnancies with fetal nuchal translucency thicknesses above the 95th centile of the normal range. The positive and negative predictive values for this cut off point of nuchal translucency thickness were 1.5% and 99.9% respectively.
CONCLUSIONS: Measurement of fetal nuchal translucency thickness-traditionally used to identify fetuses at high risk of aneuploidy-at 10-14 weeks of gestation can identify a large proportion of fetuses with major defects of the heart and great arteries.

Entities:  

Mesh:

Year:  1999        PMID: 9880278      PMCID: PMC27679          DOI: 10.1136/bmj.318.7176.81

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  26 in total

1.  First-trimester diagnosis of fetal congenital heart disease by transvaginal two-dimensional and Doppler echocardiography.

Authors:  U Gembruch; G Knöpfle; M Chatterjee; R Bald; M Hansmann
Journal:  Obstet Gynecol       Date:  1990-03       Impact factor: 7.661

2.  First-trimester transabdominal fetal echocardiography.

Authors:  G Sharland
Journal:  Lancet       Date:  1998-05-30       Impact factor: 79.321

3.  Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.

Authors:  P P Pandya; R J Snijders; S P Johnson; M De Lourdes Brizot; K H Nicolaides
Journal:  Br J Obstet Gynaecol       Date:  1995-12

4.  Fetal echocardiographic screening for congenital heart disease: the importance of the four-chamber view.

Authors:  J A Copel; G Pilu; J Green; J C Hobbins; C S Kleinman
Journal:  Am J Obstet Gynecol       Date:  1987-09       Impact factor: 8.661

5.  Congenital heart disease in 56,109 births. Incidence and natural history.

Authors:  S C Mitchell; S B Korones; H W Berendes
Journal:  Circulation       Date:  1971-03       Impact factor: 29.690

6.  Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.

Authors:  J A Hyett; M Perdu; G K Sharland; R S Snijders; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  1997-10       Impact factor: 7.299

7.  First-trimester transabdominal fetal echocardiography.

Authors:  J S Carvalho; G Moscoso; Y Ville
Journal:  Lancet       Date:  1998-04-04       Impact factor: 79.321

8.  Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.

Authors:  K H Nicolaides; G Azar; D Byrne; C Mansur; K Marks
Journal:  BMJ       Date:  1992-04-04

9.  Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study.

Authors:  C Ferencz; J D Rubin; R J McCarter; J I Brenner; C A Neill; L W Perry; S I Hepner; J W Downing
Journal:  Am J Epidemiol       Date:  1985-01       Impact factor: 4.897

10.  Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population.

Authors:  L S Chitty; G H Hunt; J Moore; M O Lobb
Journal:  BMJ       Date:  1991-11-09
View more
  39 in total

Review 1.  Antenatal diagnosis of heart disease.

Authors:  L Allan
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  Screening for Down's syndrome. Antenatal screening has human costs.

Authors:  Josephine Venn-Treloar
Journal:  BMJ       Date:  2002-01-12

3.  Prenatal diagnosis of structural heart disease: does it make a difference to survival?

Authors:  I D Sullivan
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

Review 4.  Indications for fetal echocardiography.

Authors:  M Small; J A Copel
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

5.  Prenatal Aneuploidies Computerized Screening (SCA TEST): a pilot study on 1000 women.

Authors:  Alessandro Sacco; Claudio Coco; Lucia Mangiafico; Pietro Cignini; Alessandra Tiezzi; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2007-10

6.  Fetal cardiac function during the first trimester of pregnancy.

Authors:  Oriana Valenti; Fosca A F Di Prima; Eliana Renda; Marianna Faraci; Entela Hyseni; Roberta De Domenico; Santo Monte; Elsa Giorgio
Journal:  J Prenat Med       Date:  2011-07

Review 7.  Pregnancy and congenital heart disease.

Authors:  Anselm Uebing; Philip J Steer; Steve M Yentis; Michael A Gatzoulis
Journal:  BMJ       Date:  2006-02-18

8.  Improving the effectiveness of routine prenatal screening for major congenital heart defects.

Authors:  J S Carvalho; E Mavrides; E A Shinebourne; S Campbell; B Thilaganathan
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 9.  Prenatal diagnosis and treatment planning of congenital heart defects-possibilities and limits.

Authors:  Mathias Nelle; Luigi Raio; Mladen Pavlovic; Thierry Carrel; Daniel Surbek; Matthias Meyer-Wittkopf
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

10.  Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies.

Authors:  J S Carvalho; G Moscoso; A Tekay; S Campbell; B Thilaganathan; E A Shinebourne
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.